Treatment center and geographic variability in pre-ESRD care associate with increased mortality.
about
Interstate Variation in Receipt of Nephrologist Care in US Patients Approaching ESRD: Race, Age, and State Characteristics.The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD.Patient care staffing levels and facility characteristics in U.S. hemodialysis facilities.Signs and symptoms associated with earlier dialysis initiation in nursing home residentsForm CMS-2728 data versus erythropoietin claims data: implications for quality of care studies.Efficacy of an internet-based tool for improving physician knowledge of chronic kidney disease: an observational study.Perceptions and use of the national kidney foundation KDOQI guidelines: a survey of U.S. renal healthcare providers.Characteristics and performance of minority-serving dialysis facilitiesState medicaid coverage, ESRD incidence, and access to careConfounders of mortality and hospitalization rate calculations for profit and nonprofit dialysis facilities: analytic augmentationMeeting KDOQI guideline goals at hemodialysis initiation and survival during the first yearGeographic concentration of poverty and arteriovenous fistula use among ESRD patientsThe association between geographic proximity to a dialysis facility and use of dialysis cathetersGeographic variation in cardioprotective antihypertensive medication usage in dialysis patients.Racial composition of residential areas associates with access to pre-ESRD nephrology care.Regional differences in dialysis care and mortality among American Indians and Alaska Natives.Differences in quality of life of hemodialysis patients between dialysis centersPre-Dialysis Visits to a Nephrology Department and Major Cardiovascular Events in Patients Undergoing Dialysis.High one year mortality in adults with sickle cell disease and end-stage renal disease.Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USAGeographic variation in HMG-CoA reductase inhibitor use in dialysis patients.Regional variation in the incidence of dialysis-requiring AKI in the United StatesPre-end-stage renal disease care not associated with dialysis facility neighborhood poverty in the United States.Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis.Geographic and facility-level variation in the use of peritoneal dialysis in Canada: a cohort study.Delivering Better Quality of Care: Relentless Focus and Starting with the End in Mind at DaVita.Racial and ethnic disparities in end stage renal disease: access failure.Border Health: State-Level Variation in Predialysis Nephrology Care.Association of the frequency of pre-end-stage renal disease medical care with post-end-stage renal disease mortality and hospitalization.Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition.Tough choices: dialysis, palliative care, or a third option for elderly ESRD.
P2860
Q30278550-F07FD49F-3723-4E87-858F-741B106E0064Q30413928-634AD159-E1CD-4863-8B6E-D56B6F1776B1Q30415968-B5D25B56-1A0E-400E-B8FF-58C864E81380Q30497462-0742CE33-3028-475C-9C7A-7B2802FE42C1Q30580993-CCAF177C-E3E2-42D6-B467-BAC956491AB5Q31100994-87659B5A-2A26-43D4-90F9-E038ADB6BA92Q33592790-5B56C8A3-0C6D-4673-A554-54B89A6F18ACQ33624998-8C626E6A-A747-4C6F-A597-6A4247D708F7Q33660593-A0905D98-F89D-49CA-A6C8-0CA775C0E640Q33962772-C87C2837-090B-4722-835C-219A01376AE8Q34281463-DA15F57E-62FE-45E1-9B18-B161663B28FEQ34455416-2FF3FFFC-E606-44A2-906B-FB74FC95FEBDQ35103992-FED833BC-0776-4233-8925-0FCC27C412CFQ35120709-927E29D9-DC9B-4E0F-979B-5C207D9D4231Q35153214-127B362C-6016-4D32-A588-CB0BD9FE4A90Q35647881-1E0ED8B7-D407-426E-8DE9-8769D1729B10Q35748688-CF975968-BE51-4436-A65B-CBEF9D005368Q35930559-F6861F25-6D80-4223-8110-7792DAF6F91AQ36035191-35749927-5F19-498E-9D47-7D4AF911BD5EQ36306793-10E10521-1999-49A5-BE02-2E04688E51B1Q36331383-88001909-B58C-4CCB-9AA0-765B5B8E6A33Q37247010-4D458B4F-1537-45FD-95EB-786FDC9CCE8CQ37645533-7EC41B20-F0AC-4F58-93FA-AA681ACE18CFQ37684471-21E33E42-C697-4EC0-AE30-39728A2F7D00Q37701772-42E38005-5ECC-4913-9D6D-20749690C441Q38922559-A67E8A49-BC71-461E-AF99-46EDD9CBAFCCQ42677605-DDDF3CD0-DFFF-4BFD-9F59-4EE7AA2ABC24Q43187540-6F5E5524-D76E-4BAF-B760-7FFBFF4FF1E3Q46471399-13AF6F17-0691-484D-B6B4-D2D3F0267290Q46854252-060D9D20-28E6-4A48-8690-CE84D39B0C88Q50552756-29CC8A00-7AD9-429F-9DDE-5ADB57672602
P2860
Treatment center and geographic variability in pre-ESRD care associate with increased mortality.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment center and geographi ...... iate with increased mortality.
@en
Treatment center and geographi ...... iate with increased mortality.
@nl
type
label
Treatment center and geographi ...... iate with increased mortality.
@en
Treatment center and geographi ...... iate with increased mortality.
@nl
prefLabel
Treatment center and geographi ...... iate with increased mortality.
@en
Treatment center and geographi ...... iate with increased mortality.
@nl
P2093
P2860
P356
P1476
Treatment center and geographi ...... iate with increased mortality.
@en
P2093
Ann C McClellan
Haimanot Wasse
Lance A Waller
Michael V Rocco
William M McClellan
P2860
P304
P356
10.1681/ASN.2008060624
P577
2009-03-25T00:00:00Z